ROIV 250117 7.50C (ROIV250117C7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

ROIV250117C7500

Watchlist

3.66
+0.36+10.91%

15min DelayClose Jan 17 16:00 ET

3.66High3.60Low

Intraday

5D
Daily

News

Unusual Options Activity: MSTR, UBER and Others Attract Market Bets, MSTR V/OI Ratio Reaches 210.3
Moomoo News11:30 ET
Vivek Ramaswamy Open to Replacing JD Vance in Senate -- If Offered -- WSJ
WSJJan 15 17:53 ET
Roivant Sciences Increases Stake in Immunovant With $336.9 Million Purchase
InvestingJan 15 16:40 ET
BofA Securities Maintains Roivant Sciences(ROIV.US) With Hold Rating
Moomoo NewsJan 14 06:31 ET · Ratings
Bank of America Securities Reaffirms Their Hold Rating on Roivant Sciences (ROIV)
TipRanksJan 14 06:30 ET · Ratings
Scipher Medicine and Roivant Partner to Bring Precision Medicine Insights to Rheumatology Drug Discovery and Development
BusinesswireJan 13 09:00 ET

Comments

104129527

Dec 12, 2024 08:55

$Roivant Sciences (ROIV.US)$ Founder vivek ramaswamy going take action with Elon musk.

Meltyy

Dec 5, 2024 06:32

🚀 12 upcoming PDUFAs in December ❄️

Buckle up! See FDA PDUFA update 👇🧵
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...

Jaguar8

Dec 3, 2024 06:07

NEWS

$Roivant Sciences (ROIV.US)$
Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
6 minutes ago, 4:00 AM PST
Via GlobeNewswire
ROIVROIVW
Share
• Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis
• Further development of namilumab for the treatment of sarcoidosis will be discontinued

Meltyy

May 16, 2024 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Movers and Shakers

Apr 2, 2024 07:16

Columns Today's Morning Movers and Top Ratings: DIS, DASH, CVS, GE and More

Morning Movers
Gapping up
$DoorDash (DASH.US)$ stock rose 0.4% after CFRA Research upgraded its investment stance on the food delivery platform to buy from hold, citing its high growth potential.
$Roivant Sciences (ROIV.US)$ stock rose 7.2% after the biotech said its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study.
Gapping down
$NIO Inc (NIO.US)$ fell ...